Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1982 1
1983 2
1988 1
1989 1
1991 3
1992 3
1994 1
1995 2
1996 3
1998 1
1999 3
2000 2
2001 1
2002 2
2003 1
2004 2
2005 1
2006 2
2007 4
2008 3
2009 2
2010 2
2014 1
2016 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Non-viral precision T cell receptor replacement for personalized cell therapy.
Foy SP, Jacoby K, Bota DA, Hunter T, Pan Z, Stawiski E, Ma Y, Lu W, Peng S, Wang CL, Yuen B, Dalmas O, Heeringa K, Sennino B, Conroy A, Bethune MT, Mende I, White W, Kukreja M, Gunturu S, Humphrey E, Hussaini A, An D, Litterman AJ, Quach BB, Ng AHC, Lu Y, Smith C, Campbell KM, Anaya D, Skrdlant L, Huang EY, Mendoza V, Mathur J, Dengler L, Purandare B, Moot R, Yi MC, Funke R, Sibley A, Stallings-Schmitt T, Oh DY, Chmielowski B, Abedi M, Yuan Y, Sosman JA, Lee SM, Schoenfeld AJ, Baltimore D, Heath JR, Franzusoff A, Ribas A, Rao AV, Mandl SJ. Foy SP, et al. Among authors: franzusoff a. Nature. 2023 Mar;615(7953):687-696. doi: 10.1038/s41586-022-05531-1. Epub 2022 Nov 10. Nature. 2023. PMID: 36356599 Free PMC article. Clinical Trial.
Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapy.
Puig-Saus C, Sennino B, Peng S, Wang CL, Pan Z, Yuen B, Purandare B, An D, Quach BB, Nguyen D, Xia H, Jilani S, Shao K, McHugh C, Greer J, Peabody P, Nayak S, Hoover J, Said S, Jacoby K, Dalmas O, Foy SP, Conroy A, Yi MC, Shieh C, Lu W, Heeringa K, Ma Y, Chizari S, Pilling MJ, Ting M, Tunuguntla R, Sandoval S, Moot R, Hunter T, Zhao S, Saco JD, Perez-Garcilazo I, Medina E, Vega-Crespo A, Baselga-Carretero I, Abril-Rodriguez G, Cherry G, Wong DJ, Hundal J, Chmielowski B, Speiser DE, Bethune MT, Bao XR, Gros A, Griffith OL, Griffith M, Heath JR, Franzusoff A, Mandl SJ, Ribas A. Puig-Saus C, et al. Among authors: franzusoff a. Nature. 2023 Mar;615(7953):697-704. doi: 10.1038/s41586-023-05787-1. Epub 2023 Mar 8. Nature. 2023. PMID: 36890230 Free PMC article.
Yeasts encoding tumour antigens in cancer immunotherapy.
Franzusoff A, Duke RC, King TH, Lu Y, Rodell TC. Franzusoff A, et al. Expert Opin Biol Ther. 2005 Apr;5(4):565-75. doi: 10.1517/14712598.5.4.565. Expert Opin Biol Ther. 2005. PMID: 15934834 Review.
Insulinomimetic homology of concanavalin A.
Franzusoff AJ. Franzusoff AJ. Med Hypotheses. 1983 Mar;10(3):223-8. doi: 10.1016/0306-9877(83)90111-1. Med Hypotheses. 1983. PMID: 6348492
Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy.
Mandl SJ, Rountree RB, Dela Cruz TB, Foy SP, Cote JJ, Gordon EJ, Trent E, Delcayre A, Franzusoff A. Mandl SJ, et al. Among authors: franzusoff a. J Immunother Cancer. 2014 Oct 14;2(1):34. doi: 10.1186/s40425-014-0034-0. eCollection 2014. J Immunother Cancer. 2014. PMID: 25328681 Free PMC article.
A role for CD95 ligand in preventing graft rejection.
Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. Bellgrau D, et al. Among authors: franzusoff a. Nature. 1995 Oct 19;377(6550):630-2. doi: 10.1038/377630a0. Nature. 1995. PMID: 7566174
Human ARF4 expression rescues sec7 mutant yeast cells.
Deitz SB, Wu C, Silve S, Howell KE, Melançon P, Kahn RA, Franzusoff A. Deitz SB, et al. Among authors: franzusoff a. Mol Cell Biol. 1996 Jul;16(7):3275-84. doi: 10.1128/MCB.16.7.3275. Mol Cell Biol. 1996. PMID: 8668142 Free PMC article.
44 results